CASI PHARMACEUTICALS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
CASI PHARMACEUTICALS, INC. had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $557.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2019-11-12
- 2019-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $557.00K.
- 2019-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $716.66K.
- 2019-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $957.59K.
- 2018-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $912.00K; Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value as first filed $912.20K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value as first filed |
|---|---|---|
| 2019-09-30 | $557.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $716.66K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $957.59K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $912.00K 10-Q · filed 2019-11-12 | $912.20K 10-K · filed 2019-03-29 |
| 2017-12-31 | $1.23M 10-K · filed 2019-03-29 |